916 related articles for article (PubMed ID: 27444201)
21. Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.
Bonnefoy A; Daenens K; Feys HB; De Vos R; Vandervoort P; Vermylen J; Lawler J; Hoylaerts MF
Blood; 2006 Feb; 107(3):955-64. PubMed ID: 16204318
[TBL] [Abstract][Full Text] [Related]
22. Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activity.
Yagi H; Yamaguchi N; Shida Y; Sugimoto M; Tubaki K; Fujimura Y; Matsumoto M
Thromb Res; 2017 Nov; 159():91-95. PubMed ID: 29040872
[TBL] [Abstract][Full Text] [Related]
23. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
24. ADAMTS13 deficiency promotes microthrombosis in a murine model of diet-induced liver steatosis.
Geys L; Bauters D; Roose E; Tersteeg C; Vanhoorelbeke K; Hoylaerts MF; Lijnen RH; Scroyen I
Thromb Haemost; 2017 Jan; 117(1):19-26. PubMed ID: 27604194
[TBL] [Abstract][Full Text] [Related]
25. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy.
Gragnano F; Sperlongano S; Golia E; Natale F; Bianchi R; Crisci M; Fimiani F; Pariggiano I; Diana V; Carbone A; Cesaro A; Concilio C; Limongelli G; Russo M; Calabrò P
Mediators Inflamm; 2017; 2017():5620314. PubMed ID: 28634421
[TBL] [Abstract][Full Text] [Related]
26. Extracellular Vimentin/VWF (von Willebrand Factor) Interaction Contributes to VWF String Formation and Stroke Pathology.
Fasipe TA; Hong SH; Da Q; Valladolid C; Lahey MT; Richards LM; Dunn AK; Cruz MA; Marrelli SP
Stroke; 2018 Oct; 49(10):2536-2540. PubMed ID: 30355099
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.
Tati R; Kristoffersson AC; Manea Hedström M; Mörgelin M; Wieslander J; van Kooten C; Karpman D
EBioMedicine; 2017 Feb; 16():302-311. PubMed ID: 28139439
[TBL] [Abstract][Full Text] [Related]
28. Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice.
Groeneveld D; Cline-Fedewa H; Baker KS; Williams KJ; Roth RA; Mittermeier K; Lisman T; Palumbo JS; Luyendyk JP
J Hepatol; 2020 Jan; 72(1):146-155. PubMed ID: 31606553
[TBL] [Abstract][Full Text] [Related]
29. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury.
Fujioka M; Nakano T; Hayakawa K; Irie K; Akitake Y; Sakamoto Y; Mishima K; Muroi C; Yonekawa Y; Banno F; Kokame K; Miyata T; Nishio K; Okuchi K; Iwasaki K; Fujiwara M; Siesjö BK
Neurol Sci; 2012 Oct; 33(5):1107-15. PubMed ID: 22212812
[TBL] [Abstract][Full Text] [Related]
30. Human neutrophil peptide-1 inhibits thrombus formation under arterial flow via its terminal free cysteine thiols.
McDaniel JK; Abdelgawwad MS; Hargett A; Renfrow MB; Bdeir K; Cao W; Cines DB; Zheng XL
J Thromb Haemost; 2019 Apr; 17(4):596-606. PubMed ID: 30741476
[TBL] [Abstract][Full Text] [Related]
31. Inflammation, von Willebrand factor, and ADAMTS13.
Chen J; Chung DW
Blood; 2018 Jul; 132(2):141-147. PubMed ID: 29866815
[TBL] [Abstract][Full Text] [Related]
32. Fn-EDA (Fibronectin Containing Extra Domain A) in the Plasma, but Not Endothelial Cells, Exacerbates Stroke Outcome by Promoting Thrombo-Inflammation.
Dhanesha N; Chorawala MR; Jain M; Bhalla A; Thedens D; Nayak M; Doddapattar P; Chauhan AK
Stroke; 2019 May; 50(5):1201-1209. PubMed ID: 30909835
[TBL] [Abstract][Full Text] [Related]
33. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.
Zhao BQ; Chauhan AK; Canault M; Patten IS; Yang JJ; Dockal M; Scheiflinger F; Wagner DD
Blood; 2009 Oct; 114(15):3329-34. PubMed ID: 19687510
[TBL] [Abstract][Full Text] [Related]
34. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B.
Rayes J; Hollestelle MJ; Legendre P; Marx I; de Groot PG; Christophe OD; Lenting PJ; Denis CV
Blood; 2010 Jun; 115(23):4870-7. PubMed ID: 20200350
[TBL] [Abstract][Full Text] [Related]
35. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
[TBL] [Abstract][Full Text] [Related]
36. Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions.
Golder M; Pruss CM; Hegadorn C; Mewburn J; Laverty K; Sponagle K; Lillicrap D
Blood; 2010 Jun; 115(23):4862-9. PubMed ID: 20371742
[TBL] [Abstract][Full Text] [Related]
37. Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice.
Witsch T; Martinod K; Sorvillo N; Portier I; De Meyer SF; Wagner DD
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29367415
[TBL] [Abstract][Full Text] [Related]
38. Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.
Goertz L; Schneider SW; Desch A; Mayer FT; Koett J; Nowak K; Karampinis I; Bohlmann MK; Umansky V; Bauer AT
Oncotarget; 2016 Oct; 7(42):68527-68545. PubMed ID: 27602496
[TBL] [Abstract][Full Text] [Related]
39. Elevated LDL Cholesterol Increases Microvascular Endothelial VWF and Thromboinflammation After Myocardial Infarction.
Ozawa K; Packwood W; Varlamov O; Muller M; Xie A; Wu MD; Abraham-Fan RJ; López JA; Lindner JR
Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):1041-1053. PubMed ID: 37128919
[TBL] [Abstract][Full Text] [Related]
40. von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.
Chauhan AK; Kisucka J; Lamb CB; Bergmeier W; Wagner DD
Blood; 2007 Mar; 109(6):2424-9. PubMed ID: 17119108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
